Abstract
It is established that in the main group trekrezan application in addition to basic chemotherapy, caused earlier (for 7-10 days) increase in concentration of LF — from 396.32±24.82 to 4069.32±114.06 ng/ml and F — from 26.2±1.8 ng/ml to 439.47±16.3 ng/ml, in comparison with group of control — 1335.41±39.71 ng/ml and 279.47±14.3 ng/ml, respectively. At the same time, classical clinical effectiveness indicators (concentration of total protein, urea, hemoglobin, erythrocytes, leukocytes and blood lymphocytes) were normalized in the main group of patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
